Daily non-political popular news in brief.

Older is better -- Top-10 comparison of diabetes drugs give metformin top grade

Type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

Read more »

Keywords: older, top-10, comparison, diabetes, drugs, metformin, top, grade, diabete, drug

« Previous | Next »

Similar news on "Older is better -- Top-10 comparison of diabetes drugs give metformin top grade":

1. Diabetes medication and lifestyle changes can help treat weight gain induced by antipsychotic drugs
   01-08-2008 · EurekAlert!
   Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the Jan. 9/16 issue of JAMA.
   Similar news · Read more »
   
2. OCT1 required for therapeutic effects of diabetes drug Metformin
   05-01-2007 · EurekAlert!
   Metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes. Mouse and human studies led by Kathleen Giacomini from the University of California, San Francisco, and reported in the May 1 issue of the JCI indicate that organic cation transporter 1 is important in mediating the therapeutic effects of metformin and that genetic variation in OCT1 in diabetics may contribute to the varied patient responses to this drug.
   Similar news · Read more »
   
3. Annals of Internal Medicine tip sheet for July 17, 2007
   07-16-2007 · EurekAlert!
   In this issue: Review finds older diabetes drugs have similar or superior effects to newer, pricier medications; Gonorrhea is becoming resistant to latest antibiotic; and Study: Low prevalence of gonorrhea, heavy incidence of chlamydia in US.
   Similar news · Read more »
   
4. Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
   11-08-2006 · EurekAlert!
   Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
   Similar news · Read more »
   
5. Hopkins scientists uncover cause of antipsychotic drug weight gain
   02-12-2007 · EurekAlert!
   Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.
   Similar news · Read more »
   
6. Enzyme structure reveals new drug targets for cancer and other diseases
   02-14-2008 · EurekAlert!
   Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
   Similar news · Read more »
   
7. Prescribing information for kidney disease far too vague
   12-06-2006 · EurekAlert!
   Prescribing information for healthcare professionals treating patients with kidney disease is too vague, concludes the latest issue of Drug and Therapeutics Bulletin (DTB). Many of the 4-5 percent of the UK population with serious chronic kidney disease are elderly people, who are often taking several different drugs. Other risk factors for the disease include diabetes and high blood pressure.
   Similar news · Read more »
   
8. Restrictive provincial drug policies may have benefits
   12-04-2006 · EurekAlert!
   Mamdani and co-authors report on their comparison of changes over time in NSAID use and upper GI bleeding rates in British Columbia, which restricts the use of these drugs, and in Ontario, which has a less restrictive drug coverage policy. Their findings suggest that a more restrictive drug coverage policy, although limiting access to drugs and their potential benefits, may protect the population from adverse drug effects.
   Similar news · Read more »
   
9. JCI table of contents: May 1, 2007
   05-01-2007 · EurekAlert!
   This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, May 1, 2007, in the JCI, including: "OCT1 required for therapeutic effects of diabetes drug Metformin"; "One genetic mutation heals another in blistering skin disease"; "Why wounds are slow to heal in diabetics"; "Researchers create 2 distinct mouse models of Omenn syndrome"; and "Deficiency in enzyme GGTase-I delays onset and severity of lung cancer in mice."
   Similar news · Read more »
   
10. Use of diabetes medication by older adults linked with increased risk of heart problems, death
    12-11-2007 · EurekAlert!
    Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the Dec. 12 issue of JAMA. The authors suggest that these results provide further evidence that this class of medication may cause more harm than good.
    Similar news · Read more »